Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children

Pediatric Blood and Cancer

Volumn 58, Issue 4, 2012, Pages 498-502

  Gonzalez, G ^a   Davidoff, A M ^a,b   Howard, S C ^a   Pui, C H ^a   Rao, B N ^a,b   Shenep, J L ^a,b   Wozniak, A ^a   Shochat, S J ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Children; Infection; Leukemia; Neutropenia; Pediatric

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; BACTEREMIA; BLOODSTREAM INFECTION; BODY MASS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; FEMALE; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MALE; NEUTROPHIL COUNT; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHOOL CHILD; SEPTIC SHOCK; THROMBOSIS;

ADOLESCENT; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFECTION; INFECTION CONTROL; MALE; POSTOPERATIVE COMPLICATIONS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; SAFETY; THROMBOSIS; TIME FACTORS;

EID: 84856837153     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24010     Document Type: Review

References (25)

1. Kim HJ, Yun J, Kim HJ, et al. Safety and effectiveness of Central venous catheterization in patients with cancer: Prospective observational study. J Korean Med Sci 2010; 25: 1748-1753.
2. Samaras P, Dold S, Braun J, et al. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology 2008; 74: 237-244.
3. Worth LJ, Seymour JF, Slavin MA. Infective and thrombotic complications of central venous catheters in patients with haematological malignancy: Prospective evaluation of nontunneled devices. Support Care Cancer 2009; 17: 811-818.
4. Carr E, Jayabose S, Stringel G, et al. The safety of central line placement prior to treatment of pediatric acute lymphoblastic leukemia. Pediatr Blood Cancer 2006; 47: 886-888.
5. Fratino G, Molinari AC, Parodi S, et al. Central venous catheter-related complications in children with oncological/hematological diseases: An observational study of 418 devices. Ann Oncol 2005; 16: 648-654.
6. Nosari AM, Nador G, De Gasperi A, et al. Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients. Leuk Lymphoma 2008; 49: 2148-2155.
7. Ruggiero A, Barone G, Margani G, et al. Groshong catheter-related complications in children with cancer. Pediatr Blood Cancer 2010; 54: 947-951.
8. Sauer K, Steczko J, Ash SR. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions. J Antimicrob Chemother 2009; 63: 937-945.
9. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-1272.
10. Flynn PM, Shenep JL, Barrett FF. Differential quantitation with a commercial blood culture tube for diagnosis of catheter-related infection. J Clin Microbiol 1988; 26: 1045-1046.
11. Gaur AH, Flynn PM, Giannini MA, et al. Difference in time to detection: A simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis 2003; 37: 469-475.
12. Gaur AH, Flynn PM, Heine DJ, et al. Diagnosis of catheter-related bloodstream infections in pediatric oncology patients lacking a peripheral culture, using differential time to detection. Pediatr Infect Dis J 2005; 24: 445-449.
13. Molinari AC, Castagnola E, Mazzola C, et al. Thromboembolic complications related to indwelling central venous catheters in children with oncological/hematological diseases: A retrospective study of 362 catheters. Support Care Center 2001; 9: 539-544.
14. Blyth CR, Still HA. Binomial confidence intervals. J Am Stat Assoc 1983; 78: 108-116.
15. Cox DR, Oakes D. editors. Analysis of survival data. London: Chapman & Hall/CRC; 1984.
16. Efron B, Tibshirani RJ. editors. An introduction to the bootstrap. London: Chapman & Hall/CRC; 1993.
17. Penel N, Neu JC, Clisant S, et al. Risk factors for early catheter-related infections in cancer patients. Cancer 2007; 110: 1586-1592.
18. Junqueira BL, Connolly B, Abla O, et al. Severe neutropenia at time of port insertion is not a risk factor for catheter associated infections in children with acute lymphoblastic leukemia. Cancer 2010; 116: 4368-4375.
19. Hsieh CC, Weng HH, Huang WS, et al. Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol 2009; 15: 4709-4714.
20. Mermel LA, Farr BM, Sherertz RJ, et al. Infectious diseases society of America, American college of critical care medicine, Society for healthcare epidemiology of America. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 2001; 24: 180-205.
21. Handrup MM, Moller JK, Frydenberg M, et al. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010; 55: 309-313.
22. Revel-Vilk S, Yacobovich J, Tamary H, et al. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer 2010; 116: 4197-4205.
23. Mitchell LG, Andrew M, Hanna K, et al. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: Results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study. Cancer 2003; 97: 508-516.
24. Vaudaux PE, Pittet D, Haeberli A, et al. Host factors selectively increase staphylococcal adherence on inserted catheters: A role for fibronectin and fibrinogen or fibrin. J Infect Dis 1989; 160: 865-875.
25. Vescia S, Baumgartner AK, Jacobs VR, et al. Management of venous port systems in oncology: A review of current evidence. Ann Oncol 2008; 19: 9-15.